FDA Clearance Tracker · K240468
Alkaline Phosphatase
Last checked: Nov 19, 2026Latest source record: Oct 16, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 16, 2024
Substantially Equivalent
Time to decision
239 days
Received Feb 20, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K240468
- Device name
- Alkaline Phosphatase
- Applicant location
- Irving, TX
- Received
- Feb 20, 2024
- Decided
- Oct 16, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1050
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CJE. The earliest in FDA's data is K760024, decided Aug 26, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K240468
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Abbott Laboratories Diagnostics Division
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230994 · Decided May 4, 2023 · 27 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
K202525 · Decided May 19, 2022 · 625 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
K191595 · Decided Sep 13, 2019 · 88 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.